The aims of this report are to: review the evidence about the consequences to women of developing lymphoedema; review the evidence about the prevalence of lymphoedema among women treated for breast cancer; review the evidence about possible risk factors for the development of lymphoedema and to identify any potential strategies for prevention; describe the existing management strategies for lymphoedema and evaluate the evidence about their effectiveness; and make recommendations to develop clinical management, research and patient information about lymphoedema.
Lymphoedema: prevalence, risk factors and management: a review of research
by Browning, Colette
NHMRC National Breast Cancer Centre, Kings Cross, NSW, 1997
Categories: Cancer Treatment, Lymphoedema
Subjects: Best practice, Breast cancer, Clinical practice, Lymphoedema, Prevalence, Risk factors, Therapy
Looking for this item?
Counterpart no longer offer a library service. We may be able to help you locate this item somewhere else. If you want help to find information, please call us on 1300 781 500 or send us an email. Our Resource Centre is open Monday, Wednesday and Thursday, from 10am to 5pm.
Last Updated: 27 September, 2013 2:33 pm
